The Schedule for the Assessment of Drug-Induced Movement Disorders (SADIMoD): test-retest reliability and concurrent validity

The International Journal of Neuropsychopharmacology
Anton J. M. LoonenArnold E. S. Sijben

Abstract

The SADIMoD is a newly developed instrument, consisting of a compilation of rating scales, to measure the severity of drug-induced movement disorders: dystonia, dyskinesia, Parkinsonism, akathisia, ataxia, and several types of tremors. The test-retest reliability of this scale and the concurrent validity with the Abnormal Involuntary Movement Scale (AIMS), the Simpson-Angus Scale (SEE) and the Barnes Akathisia Scale (BAS) was assessed in 31 patients [20 male/11 female; 57.1+/-16.5 yr (mean+/-S.D.)] with a variety of movement disorders by six teams of investigators. The teams were trained by means of a standard package of instruction material to such an extent that a single member of the team could represent the entire team. Each patient was rated according to the AIMS, SEE and BAS and recorded on videotape according to the SADIMoD Schedule. These video-recordings were scored twice; first, in consensus by the entire team and secondly [110.3+/-58.0 d (mean+/-S.D.) later] by a single representative of that team. One team underwent a major change between scoring and was excluded from this analysis. Despite these difficult circumstances, these first and second ratings correlated to a highly significant degree with Spearman's correla...Continue Reading

Citations

Mar 19, 2005·BMC Neurology·Sven JannoKristian Wahlbeck
Jul 11, 2008·International Journal of Geriatric Psychiatry·Wilma KnolRob J van Marum
Jan 21, 2015·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Svetlana A IvanovaAnton J M Loonen
Jul 15, 2015·Journal of Psychopharmacology·Astrid M van StrienRob J van Marum
Oct 21, 2015·The Australian and New Zealand Journal of Psychiatry·Norman Jay StomskiAmanda Meyer
Feb 12, 2004·Journal of Psychopharmacology·Thomas R E Barnes
Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Jong-Hoon KimYong Sik Kim
Jan 10, 2019·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Anastasiia S BoikoAnton J M Loonen
Sep 18, 2007·Journal of Clinical Psychopharmacology·Anton J M Loonen, Herman M van Praag
Jan 16, 2010·Journal of Clinical Psychopharmacology·Wilma KnolRob J van Marum
Sep 30, 2005·International Clinical Psychopharmacology·Lowijs N M Perquin
Sep 10, 2020·Journal of Psychopharmacology·Anton Jm Loonen, Svetlana A Ivanova
Sep 19, 2019·Nordic Journal of Psychiatry·Bernhard WeidleToshiya Inada
Apr 25, 2018·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Tamara PringsheimThomas R E Barnes
May 12, 2020·Frontiers in Molecular Neuroscience·Ivan V PozhidaevSvetlana A Ivanova
Jul 9, 2020·Journal of Clinical Psychopharmacology·Stanley N CaroffE Cabrina Campbell
May 6, 2020·The Application of Clinical Genetics·Ivan V PozhidaevSvetlana A Ivanova
Oct 17, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Anastasia LevchenkoSvetlana A Ivanova

❮ Previous
Next ❯

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Related Papers

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Sven JannoKristian Wahlbeck
© 2021 Meta ULC. All rights reserved